The takeaway
CONMED Corporation shows a moderate seasonal pattern over 10 years of data — strongest in March (+0.5%) and softest in September (−3.4%).
Right now
In July, the stock has fallen 50% of years, averaging −1.1%, roughly 3.3 pts behind the S&P 500.
The full picture
CONMED Corporation's most dependable month has been March, higher in 9 of 10 years; September has been its least reliable, up just 30% of the time.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Win rate % | ||||||||||||
| Median return % | ||||||||||||
| 2025 | ||||||||||||
| 2024 | ||||||||||||
| 2023 | ||||||||||||
| 2022 | ||||||||||||
| 2021 | ||||||||||||
| 2020 | ||||||||||||
| 2019 | ||||||||||||
| 2018 | ||||||||||||
| 2017 | ||||||||||||
| 2016 |
Month by month
The stock's clearest edge over the S&P 500 lands in April (+3.2 pts); it has trailed the market most in July (−3.3 pts).
“vs S&P” is CONMED Corporation’s average for a month minus the S&P 500’s average for that same month — isolating CONMED Corporation’s own seasonal edge from broad market drift.
Reality check
Over the last 5 years, March has closed higher 100% of the time versus 90% across the last 10 years — the pattern is holding.
Figures are the typical (median) March return and how often it rose — the last 5 years versus the last 10(the heatmap’s default window). This verdict stays anchored to that 10-year window even if you zoom the chart, so it never disagrees with the badges above.
In plain English
This is a stock you can almost set a calendar by, and March is the anchor — it has closed higher in 9 of 10 Marches, the steadiest beat on its year.
The strength looks broad-based rather than freakish: its average (+0.5%) and median (+5.8%) sit close together, so no single blow-out year is flattering the figure. That reliability comes with real swings, mind — even March ranges by 14.1% from year to year, so any single year can land far from the average. Few peers keep such company in March — the typical stock clears it just 56% of the time.
It doesn't stand entirely alone — January, August, and November have leaned firm as well, if less emphatically. On the other side of the ledger, September has been the soft spot — the weakest of 3 months that average a loss (−3.4%), and the edge isn't year-round — the stock has trailed the S&P 500 in July, September, and December.
March has now closed higher 5 years running. Reassuringly, the tendency has held its shape: the recent five years still track the years behind them.
For a stock this dependable in March, the sharper question is the rest of the year — outside its strong stretch, the calendar gives far less to lean on.
Short answers on the stock's best month (March), its worst (September), and whether it really trades seasonally.
Yes, to a moderate degree. Since 2016 its best month (March, +0.5%) has run well ahead of its worst (September, −3.4%) — the heatmap above shows how steady that gap has been year to year.
March has been the strongest, averaging +0.5% and closing higher in 9 of 10 years since 2016.
It's the weakest, averaging −3.4% — historically a soft spot, though it still varies from year to year.
Explore
These names have the strongest July track records on record — a starting point for comparison.
Before you trade